Intrexon | XON - Trade Debtors


Intrexon reported $1.02M in Trade Debtors for its fiscal quarter ending in June of 2024.





Trade Debtors Change Date
Agenus USD 22.44M 1.14M Dec/2025
Alaunos Therapeutics USD 2K 0 Jun/2025
Amgen USD 9.57B 1.08B Dec/2025
Anika Therapeutics USD 29.33M 661K Dec/2025
Arrowhead Research USD 218.87M 212.05M Dec/2025
AstraZeneca USD 19.05B 1.49B Dec/2025
Bristol-Myers Squibb USD 14.62B 485M Sep/2025
Gilead Sciences USD 4.91B 182M Dec/2025
GlaxoSmithKline GBP 7.76B 545M Dec/2025
Heron Therapeutics USD 89.59M 8.54M Dec/2025
Incyte USD 1.02B 128.52M Dec/2025
Intrexon USD 1.02M 559K Jun/2024
Karyopharm Therapeutics USD 26.18M 5.6M Dec/2025
Ligand Pharmaceuticals USD 58.1M 15.98M Sep/2025
MacroGenics USD 13.37M 55.86M Dec/2025
MannKind USD 38.37M 20.98M Dec/2025
Merck USD 12.12B 596M Sep/2025
Novartis USD 12.29B 3.3B Dec/2025
Rigel Pharmaceuticals USD 28.9M 1.39M Jun/2024
Roche Holding CHF 11.9B 460M Dec/2025
Sangamo BioSciences USD 581K 110K Jun/2024
Thermo Fisher Scientific USD 8.9B 11M Dec/2025
Veracyte USD 44.66M 3.17M Dec/2025
Xencor USD 29.3M 7.49M Dec/2025